Download Citation
Article Source:
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer
Janjigian YY,
Vakiani E,
Ku GY,
Herrera JM,
Tang LH,
et al.
(2015)
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer.
PLOS ONE 10(8): e0134731.
https://doi.org/10.1371/journal.pone.0134731